MedPath

Comparison of cinnarizine and topiramate in migraine prophylaxis

Not Applicable
Conditions
Condition 1: Common migraine. Condition 2: Classical migraine.
Migraine without aura [common migraine]
Migraine with aura [classical migraine]
Registration Number
IRCT201201028323N5
Lead Sponsor
Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
126
Inclusion Criteria

more than 4 and less than 10 attacks monthly ; interval between attacks more than 48 hours ; age at the onset of headache less than 50 years ; age 18-65 years ; not being pregnant or breast feeding ; discontinuation of other prophylactic drugs one month prior to the study
Exclusion criteria: non-migraine headaches ; overuse of medications in migraine attacks (consumption of NSAID, Ergots or Triptans more than 8 days a month) ; substance and alcohol abuse ; illiteracy of patients and their family (unable to fill diaries)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of headache. Timepoint: in each migraine attack. Method of measurement: patient will record the headache severity in daily notes as VAS (from 1 to 10) & physician registers them every 4 weeks.;Duration of migraine attack. Timepoint: in each migraine attack. Method of measurement: patient records the hours of headache in each attack , physician register them every 4 weeks.;Headache frequency. Timepoint: every 4 week. Method of measurement: According to patients daily notes.;Analgesic use. Timepoint: every 4 week. Method of measurement: According to patients daily notes.
Secondary Outcome Measures
NameTimeMethod
Clinical side effects. Timepoint: every 4 weeks. Method of measurement: According to patients daily notes.
© Copyright 2025. All Rights Reserved by MedPath